The prospect of targeting inflammation to treat residual cardiovascular risk using the monoclonal antibody canakinumab (Ilaris) appears to be slim to none in the wake of recent decisions from ...
Allegion US, a leading security products and solutions provider, today announced the expansion of its indication trim portfolio with three new lines of Schlage Indication Solutions, a lock portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results